Next Article in Journal
Automated and Multiplexed Soft Lithography for the Production of Low-Density DNA Microarrays
Next Article in Special Issue
Using miRNA-Analyzer for the Analysis of miRNA Data
Previous Article in Journal / Special Issue
Microarray Data Processing Techniques for Genome-Scale Network Inference from Large Public Repositories
Please note that this journal is no longer accepting submissions. All previous published papers will remain fully searchable on www.mdpi.com.
Article

OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes

1
Department of Medical and Surgical Science, University Magna Graecia of Catanzaro, Catanzaro 88100, Italy
2
Department of Experimental Medicine and Clinic, University Magna Graecia of Catanzaro, Catanzaro 88100, Italy
3
ISN-CNR, Roccelletta di Borgia, Catanzaro 88100, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Massimo Negrini
Microarrays 2016, 5(4), 24; https://doi.org/10.3390/microarrays5040024
Received: 13 July 2016 / Revised: 27 August 2016 / Accepted: 19 September 2016 / Published: 23 September 2016
(This article belongs to the Special Issue Next Generation Microarray Bioinformatics)
Background: The identification of biomarkers for the estimation of cancer patients’ survival is a crucial problem in modern oncology. Recently, the Affymetrix DMET (Drug Metabolizing Enzymes and Transporters) microarray platform has offered the possibility to determine the ADME (absorption, distribution, metabolism, and excretion) gene variants of a patient and to correlate them with drug-dependent adverse events. Therefore, the analysis of survival distribution of patients starting from their profile obtained using DMET data may reveal important information to clinicians about possible correlations among drug response, survival rate, and gene variants. Methods: In order to provide support to this analysis we developed OSAnalyzer, a software tool able to compute the overall survival (OS) and progression-free survival (PFS) of cancer patients and evaluate their association with ADME gene variants. Results: The tool is able to perform an automatic analysis of DMET data enriched with survival events. Moreover, results are ranked according to statistical significance obtained by comparing the area under the curves that is computed by using the log-rank test, allowing a quick and easy analysis and visualization of high-throughput data. Conclusions: Finally, we present a case study to highlight the usefulness of OSAnalyzer when analyzing a large cohort of patients. View Full-Text
Keywords: genotyping microarrays; ADME genes; pharmacogenomics; overall survival; progression-free survival genotyping microarrays; ADME genes; pharmacogenomics; overall survival; progression-free survival
Show Figures

Graphical abstract

MDPI and ACS Style

Agapito, G.; Botta, C.; Guzzi, P.H.; Arbitrio, M.; Di Martino, M.T.; Tassone, P.; Tagliaferri, P.; Cannataro, M. OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes. Microarrays 2016, 5, 24. https://doi.org/10.3390/microarrays5040024

AMA Style

Agapito G, Botta C, Guzzi PH, Arbitrio M, Di Martino MT, Tassone P, Tagliaferri P, Cannataro M. OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes. Microarrays. 2016; 5(4):24. https://doi.org/10.3390/microarrays5040024

Chicago/Turabian Style

Agapito, Giuseppe, Cirino Botta, Pietro H. Guzzi, Mariamena Arbitrio, Maria T. Di Martino, Pierfrancesco Tassone, Pierosandro Tagliaferri, and Mario Cannataro. 2016. "OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes" Microarrays 5, no. 4: 24. https://doi.org/10.3390/microarrays5040024

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop